Nailfold videocapillaroscopy micro-haemorrhage and giant capillary counting as an accurate approach for a steady state definition of disease activity in systemic sclerosis

Table 2 Disease activity assessment of nine patients with ESSG score = 3

Patient code	15	37	43	53	65	69	89	90	93
mRSS	0	2	4	5	8	4	6	6	0
Scleredema	-	+	+	+	+	+	+	+	+
Δ¹Skin features	-	-	-	-	+	-	-	-	-
Ulcers	-	-	+	-	-	-	-	+	+
Δ¹Vascular features	-	-	-	-	+	+	+	-	+
Arthritis	+	-	-	-	-	-	+	-	-
DLCO <80% ²	+	+	+	+	-	+	-	+	-
Δ¹Cardiopulmonary features	+	+	-	+	-	-	-	-	-
ESR >30 mm/h ³	+	+	-	+	-	-	-	-	-
Hypocomplementemia	-	-	-	-	-	-	-	-	-
NVC pattern	Active	Active	Active	Early	Early	Active	Active	Active	Active
NEMO score	7	12	3	0	3	6	19	9	39
GC score	9	3	7	2	5	3	10	11	5
Cs score	7	8	7	9	9	5	8	7	7

¹Worsening in the specific involvement; ²a diffusing lung capacity for carbon monoxide below 80% of predicted value; ³an erythrocyte sedimentation rate over 30 mm/h. ESSG, European Scleroderma Study Group; mRSS, modified Rodnan skin score; DLCO, diffusing capacity; ESR, erythrocyte sedimentation rate; NVC, nailfold videocapillaroscopy; NEMO, number of micro-haemorrhages; GC, giant capillaries; Cs, capillaries.

ISSN: 1478-6362